Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
2(15%)
Results Posted
17%(1 trials)

Phase Distribution

Ph phase_2
1
8%
Ph not_applicable
10
77%
Ph phase_1
1
8%
Ph phase_3
1
8%

Phase Distribution

1

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
1(7.7%)
Phase 2Efficacy & side effects
1(7.7%)
Phase 3Large-scale testing
1(7.7%)
N/ANon-phased studies
10(76.9%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

13

all time

Status Distribution
Active(5)
Completed(6)
Other(2)

Detailed Status

Completed6
Not yet recruiting2
unknown2
Recruiting2
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (7.7%)
Phase 21 (7.7%)
Phase 31 (7.7%)
N/A10 (76.9%)

Trials by Status

not_yet_recruiting215%
enrolling_by_invitation18%
completed646%
unknown215%
recruiting215%

Recent Activity

Clinical Trials (13)

Showing 13 of 13 trials

All 13 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
13